Porcilis App Each dose (2 mL) contains: Actinobacillus pleuropneumoniae antigen concentrate...................600 mg Antigen concentrate contains: Outer Membrane Protein (OMP) antigen (Appl-L-452 strain)..............50 units Apxl antigen (App HV169 strain) ..................50 units ApxII antigen (App HV143 strain) ..................50 units ApxII + ApxIII antigen (App 2 strain) .................50 units Antigens incorporated in aqueous adjuvant contains: dl-a-Tocopherol acetate................150 mg Polysorbate 80..................60 mg Simethicone ...............100 mcg Sodium chloride ..................11 mg Formalin ................1.08 mg Water ......2 mL 150 mg 60 mg 100 mcg 11 mg ... 1.08 mg ........ 2 mL Suspension for Injection (IM)
Pays: Philippines
Langue: anglais
Source: FDA (Food And Drug Administration)
Envoyer une demande.
Ingrédients actifs:
Inactivated Actinobacillus pleuropneumoniae Vaccine (Vet.)
Disponible depuis:
MSD Animal Health (Phils.), Inc.; Distributor: MSD Animal Health (Phils.), Inc.
DCI (Dénomination commune internationale):
Inactivated Actinobacillus pleuropneumoniae Vaccine (Vet.)
Dosage:
Each dose (2 mL) contains: Actinobacillus pleuropneumoniae antigen concentrate...................600 mg Antigen concentrate contains: Outer Membrane Protein (OMP) antigen (Appl-L-452 strain)..............50 units Apxl antigen (App HV169 strain) ..................50 units ApxII antigen (App HV143 strain) ..................50 units ApxII + ApxIII antigen (App 2 strain) .................50 units Antigens incorporated in aqueous adjuvant contains: dl-a-Tocopherol acetate................150 mg Polysorbate 80..................60 mg Simethicone ...............100 mcg Sodium chloride ..................11 mg Formalin ................1.08 mg Water ......2 mL 150 mg 60 mg 100 mcg 11 mg ... 1.08 mg ........ 2 mL
forme pharmaceutique:
Suspension for Injection (IM)
Unités en paquet:
PET Bottle with rubber stopper and aluminum seal x 100 mL (Box of 1's)
Fabriqué par:
Intervet International B.V., Netherlands
Date de l'autorisation:
2022-07-19
